CALCIUM CARBONATE  (ANTACID)- calcium carbonate tablet 
Pharbest Pharmaceuticals Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredient (in each tablet)

Calcium carbonate 10 gr (648 mg, USP)

Purpose

Antacid

Uses

for relief of

Warnings


Ask a doctor before use if you have

  • kidney stone
  • a calcium-restricted diet

Ask a doctor or pharmacist before use if

you are presently taking a prescription drug. Antacids may interact with certain prescription drugs.

When using this prouct

  • do not take more than 10 tablets in 24 hours
  • do not use the maximum dosage for more than 2 weeks

Keep out of the reach of children.


Direction

Other information

Inactive ingredients

croscarmellose sodium, magnesium stearate, microcrystalline cellulose, stearic acid

Questions? Adverse drug event call:

(866) 562-2756

PHARBEST

NDC 16103-0377-11

Manufactured in the U.S.A.

Compare to Tums® active ingredient

Calcium

Carbonate

Antacid

Calcium Rich •Low Sodium Antacid

THIS PACKAGE FOR HOUSEHOLDS

WITHOUT YOUNG CHILDREN

1000 TABLETS

10 gr (648 mg)

Calcium Carbonate 648mg Product Label

CALCIUM CARBONATE   (ANTACID)
calcium carbonate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:16103-377
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CALCIUM CARBONATE (UNII: H0G9379FGK) (CARBONATE ION - UNII:7UJQ5OPE7D, CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CARBONATE648 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code PH046
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:16103-377-08100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product11/29/2006
2NDC:16103-377-111000 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product11/29/2006
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart33111/29/2006
Labeler - Pharbest Pharmaceuticals Inc. (557054835)
Registrant - Pharbest Pharmaceuticals Inc. (557054835)
Establishment
NameAddressID/FEIBusiness Operations
Pharbest Pharmaceuticals Inc.557054835analysis(16103-377) , manufacture(16103-377) , pack(16103-377) , label(16103-377)

Revised: 1/2021
Document Id: 636b0d60-42c0-487e-96ff-e612695b2556
Set id: 98041570-993e-4ab4-8565-1f8c0b5e433a
Version: 2
Effective Time: 20210111
 
Pharbest Pharmaceuticals Inc.